PPA
ALT icon

Parametric Portfolio Associates’s Altimmune ALT Stock Holding History

Parametric Portfolio Associates’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,832
Closed -$200K – 3673
2021
Q4 		$200K Sell
21,832
-4,913
-18% -$52.2K ﹤0.01% 3424
2021
Q3 		$302K Buy
26,745
+2,964
+12% +$36K ﹤0.01% 3302
2021
Q2 		$234K Buy
23,781
+5,719
+32% +$78.2K ﹤0.01% 3350
2021
Q1 		$255K Buy
+18,062
New +$292K ﹤0.01% 3782
2017
Q2 		– Sell
-74
Closed -$18K – 3992
2017
Q1 		$18K Buy
74
+4
+6% +$2.14K ﹤0.01% 3767
2016
Q4 		$69K Buy
+70
New +$62.7K ﹤0.01% 3726

Other funds holding ALT

Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Parametric Portfolio Associates's ALT Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Altimmune (ALT) in Q1 2022, closing a stake of 21,832 shares — an estimated $200K sold.

Parametric Portfolio Associates first reported a position in ALT in Q4 2016 and held it in 6 quarters. The position peaked at $302K in Q3 2021. 103 funds tracked by Wall St. Rank hold ALT as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Altimmune position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 21,832 Altimmune shares in Q1 2022, an estimated $200K.
  • Parametric Portfolio Associates first reported a position in Altimmune in Q4 2016 and held it in 6 quarters.
  • Parametric Portfolio Associates's Altimmune position peaked at $302K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Altimmune as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.